Revenue Breakdown
Composition ()
No data
Revenue Streams
AtriCure Inc (ATRC) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Appendage Management-United states, accounting for 182.1% of total sales, equivalent to $45.45M. Other significant revenue streams include Open Ablation - United states and Pain management. Understanding this composition is critical for investors evaluating how ATRC navigates market cycles within the Medical Equipment, Supplies & Distribution industry.
Profitability & Margins
Evaluating the bottom line, AtriCure Inc maintains a gross margin of 74.97%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 1.77%, while the net margin is 1.25%. These profitability ratios, combined with a Return on Equity (ROE) of -2.40%, provide a clear picture of how effectively ATRC converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, ATRC competes directly with industry leaders such as NVCR and QDEL. With a market capitalization of $1.54B, it holds a leading position in the sector. When comparing efficiency, ATRC's gross margin of 74.97% stands against NVCR's 75.82% and QDEL's 41.13%. Such benchmarking helps identify whether AtriCure Inc is trading at a premium or discount relative to its financial performance.
